RTC-30
CAS: 1423077-95-5
Ref. 3D-YGC07795
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
RTC-30 is a tricyclic dibenzazepine compound that has been reengineered to have increased potency and selectivity. RTC-30 inhibits the enzyme phosphatase, which is involved in cancer cell proliferation. The pharmacological properties of RTC-30 were assessed using assays for anti-cancer activity in xenografts. In these studies, tumor size was reduced by about 50% at the end of the study, compared to untreated control animals. RTC-30 also inhibited tumor growth in mice with implanted human prostate cancer cells, inhibiting both tumor growth and metastasis.
Propriedades químicas
Consulta técnica sobre: 3D-YGC07795 RTC-30
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
